Faculty Opinions recommendation of Senolytics improve physical function and increase lifespan in old age.
Year: 2019
Type: peer-review
Abstract: Physical function declines in old age, portending disability, increased health expenditures, and mortality.Cellular senescence, leading to tissue dysfunction, may contribute to these consequences of aging, but whether senescence can directly drive age-related pathology and be targeted therapeutically is still unclear.Here we demonstrate that transplanting relatively small numbers of senescent cells into young mice is sufficient to cause persistent physical dysfunction, as well as to spread cellular senescence to host tissues.Transplanting even fewer senescent cells had the same effect in older recipients, accompanied by reduced survival, indicating the potency of senescent cells in shortening health-and life-span.The senolytic cocktail, dasatinib plus quercetin, which causes selective elimination of senescent cells, decreased the number of naturally-occurring senescent cells and their secretion of frailty-related pro-inflammatory cytokines in explants of human adipose tissue.Moreover, intermittent oral administration of senolytics to both senescent cell-transplanted younger and naturally-aged mice alleviated physical dysfunction and increased post-treatment survival by 36% while reducing mortality hazard to 65%.Our study provides proofof-concept evidence that senescent cells can cause physical dysfunction and decreased survival even in young mice, while senolytics can enhance remaining health-and lifespan in old mice.
Author: Rebecca Mason
Institution: The University of Sydney
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: green
Awards: Minnesota Obesity Center, Cell Autonomous and Non-Autonomous Mechanisms of Aging, Estrogen receptor regulation of bone metabolism in adult mice, The role of cellular senescence in intervertebral disc aging, Physiology of Bone Metabolism in an Aging Population, G9000132058, San Antonio Nathan Shock Center of Excellence in the Biology of Aging, Genetic variant-based drug discovery targeting conserved pathways of aging, Comparative Bioenergetics of Aging
OpenAlex ID: W4249270880
